Immunohistochemical study of P53 protein expression in the development of squamous cell carcinoma of the oral mucosa
- Авторлар: Ivina A.A.1, Tigay Y.O.1, Familia Frias D.R.1, Rabinovich O.F.2, Babichenko I.I.1,2
-
Мекемелер:
- RUDN University
- Central Research Institute of Stomatology and Maxillofacial Surgery
- Шығарылым: Том 29, № 4 (2025): MEDICAL GENETICS
- Беттер: 543-553
- Бөлім: ONCOLOGY
- URL: https://journals.rcsi.science/2313-0245/article/view/359610
- DOI: https://doi.org/10.22363/2313-0245-2025-29-4-543-553
- EDN: https://elibrary.ru/ATHSRH
- ID: 359610
Дәйексөз келтіру
Толық мәтін
Аннотация
Relevance. Studies on the development of squamous cell carcinoma of the oral mucosa are of paramount importance due to the widespread of the disease and its aggressive course. When histological examination of the development of squamous cell carcinoma of the oral mucosa is not always possible to determine the first signs of malignancy. Squamous cell carcinoma can develop from epithelial hyperplasia and epithelial dysplasia of varying severity. In addition to histological research methods, immunohistochemical method is widely used for tumor diseases, in which the Ki-67 protein is used, with which the proliferation of epithelial cells can be determined, as well as the P53 protein encoding the TP53 gene, which is a suppressor of tumor growth. It is activated only in the presence of damage to the cell genome. The aim was to evaluate the expression of Ki-67 and P53 proteins in the development of dysplasia and squamous cell carcinoma of the oral mucosa. Materials and Methods. Four groups were identified for the study: group 1-16 patients (34.7%) diagnosed with epithelial hyperplasia, group 2-8 patients (17.3%) diagnosed with low-grade epithelial dysplasia, group 3-9 (19.5%) with a diagnosis of “high-grade epithelial dysplasia”, group 4-13 (28.2%) with a diagnosis of “squamous cell carcinoma”. Mouse monoclonal antibodies to Ki-67 (clone MM1, Diagnostic Biosystems, USA) was used to determine cell proliferation. P53 expression was determined using mouse monoclonal antibodies to the P53 protein (Clone D 07, Novocastra, UK). Monoclonal rabbit antibodies P53 (Clone Y5 Epitomics, USA) were used to study only the “mutant type” of the P53 protein. Results and Discussion. The expression of Ki-67 and P53 proteins were observed in all groups. However, the minimum number of immunopositive cells in the study of P53 (Clone D 07) and P53 (Clone Y5) was observed in the epithelial hyperplasia group, and the maximum in the squamous cell carcinoma group. The increase in the number of stained cells significantly increased as the degree of epithelial dysplasia increased from epithelial hyperplasia and low grade epithelial dysplasia to high grade epithelial dysplasia, etc. Conclusion. Thus, the detection of the expression of the P53 protein (Clone Y5) in the epithelium indicates the presence of changes in the genetic apparatus and metabolism of cells, which can be used in the early diagnosis of squamous cell carcinoma of the oral mucosa.
Негізгі сөздер
Авторлар туралы
Anastasia Ivina
RUDN University
Email: chen.juliya@gmail.com
ORCID iD: 0000-0001-8387-4413
SPIN-код: 7209-9893
Moscow, Russian Federation
Yuliya Tigay
RUDN University
Хат алмасуға жауапты Автор.
Email: chen.juliya@gmail.com
ORCID iD: 0000-0002-6500-9220
SPIN-код: 6896-9690
Moscow, Russian Federation
Diana Familia Frias
RUDN University
Email: chen.juliya@gmail.com
ORCID iD: 0000-0001-7878-2901
SPIN-код: 2165-2702
Moscow, Russian Federation
Olga Rabinovich
Central Research Institute of Stomatology and Maxillofacial Surgery
Email: chen.juliya@gmail.com
ORCID iD: 0000-0002-1018-9017
SPIN-код: 9614-7204
Moscow, Russian Federation
Igor Babichenko
RUDN University; Central Research Institute of Stomatology and Maxillofacial Surgery
Email: chen.juliya@gmail.com
ORCID iD: 0000-0001-5512-6813
SPIN-код: 2651-8409
Moscow, Russian Federation
Әдебиет тізімі
- Belyakova EN, Briko NI, Lopukhov PD. Characteristics of the head and neck cancer incidence potentially associated with human papillomavirus in Russia in 2007–2018. Russian Journal of Preventive Medicine. 2021;24(2):30–36. (In Russian) doi: 10.17116/profmed20212402130
- Fatkullin DМ, Guz АО, Garev АV, Zaharov АS, Sokolova МI. Oral squamous cell carcinoma in “young” patients. Uralʹskij medicinskij žurnal. 2021;2:89–94. (In Russian) doi: 10.52420/2071-5943-2021-20-2-89-94
- Dzybova EM, Vardanyan KL, Vasilevskaia EA. Squamous cell carcinoma of the skin: clinical presentation, diagnosis, treatment, and prevention. Russian Journal of Clinical Dermatology and Venereology. 2015;14(4):4–14. (In Russian) doi: 10.17116/klinderma20151444-14
- Woo SB. Oral Epithelial Dysplasia and Premalignancy. Head Neck Pathol. 2019;13(3):423–439. doi: 10.1007/s12105-019-01020-6
- Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612–627. doi: 10.1016/j.oooo.2017.12.011
- Kudryavtsev GY, Kudryavtseva LV, Mikhaleva LM, Kuryavtseva YYu, Solovyeva NA, Osipov VA, Babichenko II. Immunohistochemical study of P53 protein expression in different prostate cancer Gleason grading groups. RUDN Journal of Medicine.2020;24.2:145–155.(In Rissian) [Кудрявцев Г.Ю., Кудрявцева Л.В., Михалева Л.М., Кудрявцева Я.Ю., Соловьева Н.А., Осипов В.А., Бабиченко И.И.. Иммуногистохимическое исследование экспрессии белка Р53 в аденокарциномах предстательной железы различной степени злокачественности // Вестник РУДН. Серия: Медицина 2020. Т. 24 вып. 2. С. 145–155] doi: 10.22363/2313-0245-2020-24-2-145-155
- Gadbail AR, Sarode SC, Chaudhary MS, Gondivkar SM, Tekade SA, Yuwanati M, Sarode GS, Hande A, Patil S. Ki‑67, CD105, and α-smooth muscle actin expression in oral squamous cell carcinoma corresponds with different forms of tobacco consumption habits. J Cancer Res Ther. 2022;18:197–204. doi: 10.4103/jcrt.JCRT_1307_20
- Gadbail AR, Sarode SC, Chaudhary MS, Gondivkar SM, Tekade SA, Yuwanati M, Patil S. Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma. J Appl Oral Sci. 2021;1;29. doi: 10.1590/1678-7757-2020-0751
- Carlsen L, Zhang S, Tian X, De La Cruz A, George A, Arnoff TE, El-Deiry WS. The role of p53 in anti-tumor immunity and response to immunotherapy. Front Mol Biosci. 2023;10:1148389. doi: 10.3389/fmolb.2023.114838
- Swain S, Nishat R, Ramachandran S, Raghuvanshi M, Behura SS, Kumar H. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma. J Cancer Res Ther. 2022;18(4):997–1002.doi: 10.4103/jcrt.JCRT_10_20
- Tessier-Cloutier B, Kortekaas KE, Thompson E, Pors J, Chen J, Ho J, Prentice LM, McConechy MK, Chow C, Proctor L, McAlpine JN, Huntsman DG, Gilks CB, Bosse T, Hoang LN. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status. Mod Pathol. 2020;33(8):1595–1605.doi: 10.1038/s41379-020-0524-1
- Babamohamadi M, Babaei E, Ahmed Salih B, Babamohammadi M, Jalal Azeez H, Othman G. Recent findings on the role of wild-type and mutant p53 in cancer development and therapy. Front Mol Biosci. 2022;9:903075. doi: 10.3389/fmolb.2022.903075
- Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, Tang Q, Feng B, Jiang L, He J, Chen G, Fu X, Xu Y. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer cell, 2019;35(2);191–203. doi: 10.1016/j.ccell.2018.12.012
- Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncology letters, 2019;18(2):1372–1380. doi: 10.3892/ol.2019.10420
- Voskarides K, Giannopoulou N. The Role of TP53 in Adaptation and Evolution. Cells, 2023;12(3):512. doi: 10.3390/cells12030512
- Kanapathipillai M. Treating p53 Mutant Aggregation-Associated Cancer. Cancers, 2018;10(6):154. doi: 10.3390/cancers10060154
- Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53‑mediated tumour suppression? Cell death and differentiation, 2018;25(1):104–113. doi: 10.1038/cdd.2017.169
- Ivina AA, Tigay YuO, Rabinovich OF, Goryachev V., Familia Frias DR, Babichenko II. Molecular genetic criteria for oral mucosal epithelial malignization. Clinical and experimental morphology. 2023;12(4):23–31 (In Russian) doi: 10.31088/CEM2023.12.4.23-31
- Singh RD, Patel KA, Patel JB, Patel PS. Alterations in p53 Influence hTERT, VEGF and MMPs Expression in Oral Cancer Patients. Asian Pacific journal of cancer prevention. 2022;23(9), 3141–3149. doi: 10.31557/APJCP.2022.23.9.3141
- Sung YN, Kim D, Kim J. Р53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations. Diagnostic pathology, 2022;17(1):92. doi: 10.1186/s13000-022-01273-w
- Le Quesne J, Maurya M, Yancheva SG, O’Brien M, Popat S, Wotherspoon, AC, de Castro D.G, Nicholson AG. A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer, 2014;9(6):769–774. doi: 10.1097/JTO.0000000000000157
Қосымша файлдар

